drugset / Trial / NCT01734707
Atherosclerosis Monitoring and Atherogenicity Reduction Study
RandomizedParallel-groupDouble-blindTreatment
Summary
This study was designed to estimate the effect of two-year treatment with time-released garlic-based drug Allicor on the progression of carotid atherosclerosis in double-blinded placebo-controlled randomized clinical trial.
Timeline
- Start
- 2004-01
- Primary completion
- 2005-01
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allicor | Traditional medicine (herbal / TCM) | 150 mg | Oral |